[EFFECT OF THE SEROTONIN ANTAGONIST DESERIL (1-METHYL-LYSERGIC ACID BUTANOLAMIDE) ON THE TOTAL CATECHOLAMINE LEVEL IN WHOLE BLOOD AND ITS ROLE IN THE CARCINOID SYNDROME (CASSIDY-SCHOLTE)].
D001774:Blood Chemical Analysis; D002276:Carcinoid Tumor; D002395:Catecholamines; D007414:Intestinal Neoplasms; D008237:Lysergic Acid; D008303:Malignant Carcinoid Syndrome; D008784:Methysergide; D010600:Pharmacology; D012701:Serotonin; D012702:Serotonin Antagonists; D017367:Selective Serotonin Reuptake Inhibitors
D002395:Catecholamines; D008237:Lysergic Acid; D008784:Methysergide; D012701:Serotonin; D012702:Serotonin Antagonists; D017367:Selective Serotonin Reuptake Inhibitors
BLOOD CHEMICAL ANALYSIS; CARCINOID TUMOR; CATECHOLAMINES; INTESTINAL NEOPLASMS; METHYSERGIDE; PHARMACOLOGY; SEROTONIN INHIBITORS
WIRKUNG DES SEROTONIN-ANTAGONISTEN DESERIL (1-METHYL-LYSERGSAEUREBUTANOLAMID)  AUF DAS NIVEAU DES GESAMTKATECHOLAMINS DES VOLLBLUTES UND SEINE ROLLE BEIM KARZINOID-SYNDROM (CASSIDY-SCHOLTE)